Handbook of Diabetes (eBook)

Rudy Bilous, Richard Donnelly, Iskandar Idris (Autoren)

eBook Download: EPUB

2021 | 5. Auflage
John Wiley & Sons (Verlag)
978-1-118-97597-8 (ISBN)

Infos

HANDBOOK OF DIABETES

The Handbook of Diabetes provides concise and efficient coverage of the diagnosis, epidemiology, and management of diabetes and its complications. Containing hundreds of attractive colour diagrams, illustrations, and clinical photographs, this popular quick-reference guide focuses on the management and measurement of diabetes mellitus with highly visual references.

Now in its fifth edition, this market-leading book aligns with the most recent guidelines from the American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD), Diabetes UK, and the National Institute for Health and Care Excellence (NICE), presenting authoritative clinical coverage of diabetes in an accessible format with rich pedagogical features.

• Five new chapters provide detailed coverage of liver disease, diabetes education, bariatric surgery, diabetes and cancer, and the use of incretin-based therapies and SGLT2 Inhibitors in the management of Type II diabetes
• Updated and expanded topics include the relation between hypoglycaemia and dementia, anxiety and depression, the NICE Quality and Outcomes Framework (QOF), and the impacts of diabetes to self-care, mental health, and decision-making
• Provides a wealth of pedagogical features such as vignettes and case histories, important learning points, summaries of key clinical trials, and links to further readings

Handbook of Diabetes, remains the essential practical companion for all health professionals involved in managing patients with diabetes, and an up-to-date reference for diabetes and endocrinology researchers, scientists, and academics.

Rudy Bilous, MD, FRCP, is Professor Emeritus of Clinical Medicine at Newcastle University, UK. He is currently Consultant in Medical Education and Honorary Consultant in Diabetes and Endocrinology at South Tees NHS Foundation Trust, Middlesbrough, UK. He was Chair of the NICE Guideline Development Group for Diabetes in Pregnancy.

Richard Donnelly, MD, PhD, FRCP, FRACP, is Professor Emeritus, School of Medicine, University of Nottingham, UK. He is currently Editor-in-Chief of Diabetes Obesity & Metabolism.

Iskandar Idris, DM, FRCP, is Associate Professor in Diabetes and Vascular Medicine at the Division of Graduate Entry Medicine and Medical Sciences, School of Medicine, University of Nottingham, UK. He is also Training Programme Director for Specialist Training in Diabetes and Endocrinology for the Health Education England East Midlands. He has published widely in the field of Diabetes and Obesity.

Inhalt

Preface ix

Key to the boxes x

List of abbreviations xi

Part 1: Introduction to diabetes 1

1 Introduction to diabetes 3

2 History of diabetes 6

3 Diagnosis and classification of diabetes 10

4 Public health aspects of diabetes 17

5 Normal physiology of insulin secretion and action, and the incretin effect 23

6 Epidemiology and aetiology of type 1 diabetes 35

7 Epidemiology and aetiology of type 2 diabetes 46

8 Other types of diabetes 57

Part 2: Metabolic control and complications 65

9 Diabetes control and its measurement 67

10 Management of type 1 diabetes 78

11 Management of type 2 diabetes 90

12 Diabetic ketoacidosis (DKA), hyperglycaemic hyperosmolar state (HHS)and lactic acidosis 100

13 Hypoglycaemia 110

14 Causes of complications 118

15 Diabetic eye disease 129

16 Diabetic nephropathy 141

17 Diabetic neuropathy 155

18 Blood lipid abnormalities 162

19 Hypertension in diabetes 168

20 Macrovascular disease in diabetes 179

21 Foot problems in diabetes 189

22 Sexual problems in diabetes 196

23 Gastrointestinal problems in diabetes 204

24 Non-alcoholic liver disease (NAFLD) 211

25 Diabetes and cancer 217

26 Skin and connective tissue disorders in diabetes 221

27 Psychological and psychiatric problems in diabetes 227

Part 3: The spectrum and organisation of diabetes care 235

28 Intercurrent situations that affect diabetes control 237

29 Pregnancy and diabetes 247

30 Diabetes in childhood and adolescence 257

31 Diabetes in old age 265

32 Diabetes and lifestyle 269

33 Organisation of diabetes care: integrating diabetes service 275

34 Transplantation and stem cell therapy 282

Index 288

Textauszug

List of abbreviations

ABPI	Ankle Brachial Pressure Index

ABPM	ambulatory blood pressure measurement

ACCORD

Action to Control Cardiovascular Risk in Diabetes

ACE	angiotensin‐converting enzyme

ACEI	angiotensin‐converting enzyme inhibitors

ACR	albumin creatinine ratio

ADA	American Diabetes Association

ADVANCE

Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation

AGE	advanced glycation endproduct

AKI	acute kidney injury

ALT	alanine aminotransferase

AMI	acute myocardial infarction

ARB	angiotensin type 1 receptor blocker

AST	aspartate aminotransferase

ATP	adenosine triphosphate

BB	BioBreeding

BMI	Body Mass Index

BP	blood pressure

CABG	coronary artery bypass grafting

CBT	cognitive behavioural therapy

CCB	calcium channel blockers

CETP	cholesterol ester transfer protein

CF	cystic fibrosis

CGM	continuous glucose monitoring

CHD	coronary heart disease

CI	confidence interval

CIDP	chronic inflammatory demyelinating polyneuropathy

CKD	chronic kidney disease

CSF	cerebrospinal fluid

CSII	continuous subcutaneous insulin infusion

CT	computed tomography

CVD	cardiovascular disease

DAFNE

Dose Adjustment for Normal Eating

DAG	diacylglycerol

DCCT	Diabetes Control and Complications Trial

DESMOND

Diabetes Education and Self‐Management Ongoing and Newly Diagnosed

DIDMOAD

diabetes insipidus diabetes mellitus optic atrophy deafness

DKA	diabetic ketoacidosis

DME	diabetes‐related macular oedema

DPP‐4

dipeptidyl peptidase‐4 (IV)

DSN	diabetes specialist nurse

DVA	Driving and Vehicle Agency

DVLA	Driving and Vehicle Licensing Authority

eAG	estimated average glucose

ED	erectile dysfunction

EDIC	Epidemiology of Diabetes Complications

eGFR	estimated glomerular filtration rate

eNOS	endothelial nitric oxide synthase

EPO	erythropoietin

ESRD	end‐stage renal disease

ETDRS

Early Treatment Diabetic Retinopathy Study

EURODIAB

European Diabetes complications

FATP	study group fatty acid transporter protein

FDA	Food and Drug Administration

FFA	free fatty acids

FPG	fasting plasma glucose

FSD	female sexual dysfunction

GAD	glutamic acid decarboxylase

GBM	glomerular basement membrane

GCK	glucokinase

GDM	gestational diabetes mellitus

GFAT	glutamine:fructose‐6‐phosphate amidotransferase

GFR	glomerular filtration rate

GI	gastrointestinal

GIP	gastric inhibitory polypeptide

GIR	glucose infusion rate

GKI	glucose potassium insulin infusion

GLP‐1

glucagon‐like peptide‐1

GLUT	glucose transporter

GWAS	genome wide association study

HBPM	home blood pressure measurement

HDL	high‐density lipoprotein

HHS	hyperosmolar hyperglycaemic state

HL	hepatic lipase

HLA	human leukocyte antigen

HOMA	Homeostasis Model Assessment

HPLC	high‐pressure liquid chromatography

HR	hazard ratio

hsCRP

high‐sensitivity C‐reactive protein

IAA	insulin autoantibody

IAPP	islet amyloid polypeptide

ICA	islet cell antibody insulin‐dependent diabetes mellitus

IFG	impaired fasting glycaemia

IGF	Insulin‐like growth factor

IGT	impaired glucose tolerance

IM	intramuscular

IPPV	intermittent positive pressure ventilation

IQR	interquartile range

IRMA	intraretinal microvascular abnormality

IRS	insulin receptor substrate

ITU	intensive therapy unit

IV	intravenous

KATP	ATP‐sensitive potassium channel

LADA	latent autoimmune diabetes of adults

LDL	low‐density lipoprotein

LH	luteinising hormone

MAP	mitogen‐activated protein

MAPK	mitogen‐activated protein kinase

MDI	multiple daily injection

MHC	major histocompatibility complex

MI	myocardial infarction

MODY	maturity‐onset diabetes of the young

mTOR	mammalian target of rapamycin

NADH	nicotinamide adenine dinucleotide plus hydrogen

NADPH

nicotinamide adenine dinucleotide

NDIP	phospate hydrogen National Diabetes in Pregnancy audit

NEFA	non‐esterified fatty acid

NDIP	National Diabetes in Pregnancy audit

NFκB	nuclear factor kappa‐light‐chain‐enhancer of activated B cells

NGT	normal glucose tolerance

NICE	National Institute of Health and Clinical Excellence

NK	natural killer

NKCF	natural killer cell factor

NLD	necrobiosis lipoidica diabeticorum

NO	nitric oxide

NOD	non‐obese diabetic

NPH	neutral protamine Hagedorn

NPY	neuropeptide Y

NVD	new vessels on the disc

NVE	new vessels elsewhere

OCT	optical coherence tomography

OGTT	oral glucose tolerance test

OR	odds ratio

PAD	peripheral arterial disease

PAI‐1

plasminogen activator...

Produkt-Details

• Erscheint lt. Verlag: 29.4.2021
• Sprache: englisch
• Themenwelt: Sachbuch/Ratgeber ► Gesundheit / Leben / Psychologie
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Innere Medizin
• Schlagworte: Allgemeinpraxis, hausärztliche Praxis • Diabetes • diabetes clinical guide • diabetes clinical handbook • diabetes clinical reference • Diabetes complications • diabetes diagnosis guide • diabetes diagnosis reference • diabetes epidemiology • Diabetes management guide • diabetes management reference • endocrinology • Endokrinologie • General Practice/Family Practice • Medical Science • Medizin
• ISBN-10: 1-118-97597-9 / 1118975979
• ISBN-13: 978-1-118-97597-8 / 9781118975978